156 related articles for article (PubMed ID: 15299198)
21. Cytokeratin staining in Merkel cell carcinoma: an immunohistochemical study of cytokeratins 5/6, 7, 17, and 20.
Jensen K; Kohler S; Rouse RV
Appl Immunohistochem Mol Morphol; 2000 Dec; 8(4):310-5. PubMed ID: 11127923
[TBL] [Abstract][Full Text] [Related]
22. A case series and immunophenotypic analysis of CK20-/CK7+ primary neuroendocrine carcinoma of the skin.
Calder KB; Coplowitz S; Schlauder S; Morgan MB
J Cutan Pathol; 2007 Dec; 34(12):918-23. PubMed ID: 18001414
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical and immunoelectron microscopic demonstration of chromogranin A in formalin-fixed tissue of Merkel cell carcinoma.
Haneke E; Schulze HJ; Mahrle G
J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):222-6. PubMed ID: 8432919
[TBL] [Abstract][Full Text] [Related]
24. Differential expression of thyroid transcription factor 1 in small cell lung carcinoma and Merkel cell tumor.
Byrd-Gloster AL; Khoor A; Glass LF; Messina JL; Whitsett JA; Livingston SK; Cagle PT
Hum Pathol; 2000 Jan; 31(1):58-62. PubMed ID: 10665914
[TBL] [Abstract][Full Text] [Related]
25. Expression of Notch-1 and alteration of the E-cadherin/beta-catenin cell adhesion complex are observed in primary cutaneous neuroendocrine carcinoma (Merkel cell carcinoma).
Panelos J; Batistatou A; Paglierani M; Zioga A; Maio V; Santi R; Pimpinelli N; De Giorgi V; Santucci M; Massi D
Mod Pathol; 2009 Jul; 22(7):959-68. PubMed ID: 19396152
[TBL] [Abstract][Full Text] [Related]
26. Lower expression of CADM1 and higher expression of MAL in Merkel cell carcinomas are associated with Merkel cell polyomavirus infection and better prognosis.
Iwasaki T; Matsushita M; Nonaka D; Nagata K; Kato M; Kuwamoto S; Murakami I; Hayashi K
Hum Pathol; 2016 Feb; 48():1-8. PubMed ID: 26772392
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of the clinicopathological significance of E-cadherin and catenins (alpha, beta, gamma) expression in the surgical management of oral tongue carcinoma.
Chow V; Yuen AP; Lam KY; Tsao GS; Ho WK; Wei WI
J Cancer Res Clin Oncol; 2001 Jan; 127(1):59-63. PubMed ID: 11206273
[TBL] [Abstract][Full Text] [Related]
28. Merkel cell carcinoma: a clinicopathological study of 11 cases.
Acebo E; Vidaurrazaga N; Varas C; Burgos-Bretones JJ; Díaz-Pérez JL
J Eur Acad Dermatol Venereol; 2005 Sep; 19(5):546-51. PubMed ID: 16164706
[TBL] [Abstract][Full Text] [Related]
29. Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors.
Lyakhovitsky A; Barzilai A; Fogel M; Trau H; Huszar M
Am J Dermatopathol; 2004 Oct; 26(5):372-8. PubMed ID: 15365368
[TBL] [Abstract][Full Text] [Related]
30. SOX11 Is an Effective Discriminatory Marker, When Used in Conjunction With CK20 and TTF1, for Merkel Cell Carcinoma: Comparative Analysis of SOX11, CK20, PAX5, and TTF1 Expression in Merkel Cell Carcinoma and Pulmonary Small Cell Carcinoma.
Cho WC; Vanderbeck K; Nagarajan P; Milton DR; Gill P; Wang WL; Curry JL; Torres-Cabala CA; Ivan D; Prieto VG; Aung PP
Arch Pathol Lab Med; 2023 Jul; 147(7):758-766. PubMed ID: 36745184
[TBL] [Abstract][Full Text] [Related]
31. Beta- and gamma-catenin expression in oral squamous cell carcinomas.
Lo Muzio L; Staibano S; Pannone G; Grieco M; Mignogna MD; Cerrato A; Testa NF; De Rosa G
Anticancer Res; 1999; 19(5B):3817-26. PubMed ID: 10628318
[TBL] [Abstract][Full Text] [Related]
32. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
[TBL] [Abstract][Full Text] [Related]
33. Merkel cells, normal and neoplastic: an update.
Sidhu GS; Chandra P; Cassai ND
Ultrastruct Pathol; 2005; 29(3-4):287-94. PubMed ID: 16036883
[TBL] [Abstract][Full Text] [Related]
34. Merkel cell carcinoma with eccrine differentiation: a clinicopathologic study of 7 cases.
Saeb-Lima M; Montante-Montes de Oca D; Albores-Saavedra J
Ann Diagn Pathol; 2008 Dec; 12(6):410-4. PubMed ID: 18995205
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma.
Ikeguchi M; Makino M; Kaibara N
J Surg Oncol; 2001 Jul; 77(3):201-7. PubMed ID: 11455558
[TBL] [Abstract][Full Text] [Related]
36. Merkel cell carcinoma with an unusual immunohistochemical profile.
Pilloni L; Manieli C; Senes G; Ribuffo D; Faa G
Eur J Histochem; 2009 Dec; 53(4):e33. PubMed ID: 22073365
[TBL] [Abstract][Full Text] [Related]
37. Association of E-cadherin and beta-catenin immunoexpression with clinicopathologic features in primary ovarian carcinomas.
Faleiro-Rodrigues C; Macedo-Pinto I; Pereira D; Ferreira VM; Lopes CS
Hum Pathol; 2004 Jun; 35(6):663-9. PubMed ID: 15188131
[TBL] [Abstract][Full Text] [Related]
38. Expression of E-cadherin, alpha- & beta-catenin, and CD44V6 and the subcellular localization of E-cadherin and CD44V6 in normal epidermis and basal cell carcinoma.
Kooy AJ; Tank B; de Jong AA; Vuzevski VD; van der Kwast TH; van Joost T
Hum Pathol; 1999 Nov; 30(11):1328-35. PubMed ID: 10571513
[TBL] [Abstract][Full Text] [Related]
39. Merkel cell carcinomas with CK20 negative and CK7 positive immunostaining.
Beer TW
J Cutan Pathol; 2009 Mar; 36(3):385-6; author reply 387. PubMed ID: 19220637
[No Abstract] [Full Text] [Related]
40. P-cadherin expression in Merkel cell carcinomas is associated with prolonged recurrence-free survival.
Vlahova L; Doerflinger Y; Houben R; Becker JC; Schrama D; Weiss C; Goebeler M; Helmbold P; Goerdt S; Peitsch WK
Br J Dermatol; 2012 May; 166(5):1043-52. PubMed ID: 22283194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
